Peter Boström - UTU Research Portal

Peter Boström

- Associate Professor,
Surgery (Department of Clinical Medicine)

peter.bostrom@utu.fi

: https://orcid.org/0000-0003-3647-0015

9 of 12

Torsio testis (2018) Kirurgia Laato Matti, Syvänen Kari, Boström Peter
Uretriitti (2018) Kirurgia Laato Matti, Syvänen Kari, Boström Peter
Varikoseele (2018) Kirurgia Laato Matti, Syvänen Kari, Boström Peter
Fitting methods for intravoxel incoherent motion imaging of prostate cancer on region of interest level: Repeatability and gleason score prediction (2017)
- Magnetic Resonance in Medicine
Harri Merisaari, Parisa Movahedi, Ileana M. Perez, Jussi Toivonen, Marko Pesola, Pekka Taimen, Peter J. Boström, Tapio Pahikkala, Aida Kiviniemi, Hannu J. Aronen, Ivan Jambor
Immunological tumor status may predict response to neoadjuvant chemotherapy and outcome after radical cystectomy in bladder cancer (2017)
- Scientific Reports
Tervahartiala M, Taimen P, Mirtti T, Koskinen I, Ecke T, Jalkanen S, Bostrom PJ
Increased FGFRL1 expression is associated with prostate cancer progression (2017)
- Cancer Research
Yu L., Toriseva M., Erickson A., Seikkula H., Nurmi M., Taimen P., Boström P., Mirtti T., Alanen K., Kallajoki M., Tuomela J., Nees M., Härkönen P.
Non-muscle-invasive bladder cancer: a vision for the future (2017)
- Scandinavian Journal of Urology
Per-Uno Malmström, Sachin Agrawal, Mats Bläckberg, Peter J. Boström, Bernard Malavaud, Dirk Zaak, Gregers G. Hermann
Novel Biparametric MRI and Targeted Biopsy Improves Risk Stratification in Men With a Clinical Suspicion of Prostate Cancer (IMPROD Trial) (2017)
- Journal of Magnetic Resonance Imaging
Jambor I, Bostrom PJ, Taimen P, Syvanen K, Kahkonen E, Kallajoki M, Perez IM, Kauko T, Matomaki J, Ettala O, Merisaari H, Kiviniemi A, Dean PB, Aronen HJ
Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic (2017)
- Journal of Clinical Oncology
Kulkarni GS, Hermanns T, Wei Y, Bhindi B, Satkunasivam R, Athanasopoulos P, Bostrom PJ, Kuk C, Li K, Templeton AJ, Sridhar SS, van der Kwast TH, Chung P, Bristow RG, Milosevic M, Warde P, Fleshner NE, Jewett MAS, Bashir S, Zlotta AR
Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study (2017)
- Journal of Magnetic Resonance Imaging
Ginsburg SB, Algohary A, Pahwa S, Gulani V, Ponsky L, Aronen HJ, Boström PJ, Böhm M, Haynes AM, Brenner P, Delprado W, Thompson J, Pulbrock M, Taimen P, Villani R, Stricker P, Rastinehad AR, Jambor I, Madabhushi A
Stage-specific mortality and survival trends of prostate cancer patients in Finland before and after introduction of PSA (2017)
- Acta Oncologica
Seikkula HA, Kaipia AJ, Rantanen ME, Pitkäniemi JM, Malila NK, Boström PJ
Benefit of Adjuvant Chemotherapy and Pelvic Lymph Node Dissection in pT3 and Node Positive Bladder Cancer Patients Treated with Radical Cystectomy. (2016)
- Bladder Cancer
Boström PJ, Mirtti T, van Rhijn B, Fleshner NE, Finelli A, Laato M, Jewett MA, Moore MJ, Sridhar S, Nurmi M, Tannock IF, Zlotta AR.
Diffusion Weighted Imaging of Prostate Cancer: Prediction of Cancer using Texture Features from Parametric Maps of the Monoexponential and Kurtosis functions (2016) 2016 Sixth International Conference on Image Processing Theory, Tools and Applications (IPTA) Ileana Montoya Perez, Jussi Toivonen, Parisa Movahedi, Harri Merisaari, Marko Pesola, Pekka Taimen, Peter J. Boström, Aida Kiviniemi, Hannu J. Aronen, Tapio Pahikkala, Ivan Jambor
Establishment of a realistic patient derived xenograft (PDX) model for prostate cancer bone metastasis (2016)
- Cancer Research
Konkol Y, Valta M, Bernoulli J, Taimen P, Bostrom P, Harkonen P, Halleen J, Tuomela JM
Global expression of AMACR transcripts predicts risk for prostate cancer - a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate (2016)
- BMC Urology
Alinezhad S, Vaananen RM, Ochoa NT, Vertosick EA, Bjartell A, Bostrom PJ, Taimen P, Pettersson K
Hypoxia Marker GLUT-1 (Glucose Transporter 1) is an Independent Prognostic Factor for Survival in Bladder Cancer Patients Treated with Radical Cystectomy (2016)
- Bladder Cancer
Boström PJ, Thoms J, Sykes J, Ahmed O, Evans A, van Rhijn BW, Mirtti T, Stakhovskyi O, Laato M, Margel D, Pintilie M, Kuk C, Milosevic M, Zlotta AR, Bristow RG
Incidence, Characteristics and Implications of Thromboembolic Events in Patients with Muscle Invasive Urothelial Carcinoma of the Bladder Undergoing Neoadjuvant Chemotherapy (2016)
- Journal of Urology
Duivenvoorden WC, Daneshmand S, Canter D, Lotan Y, Black PC, Abdi H, van Rhijn BW, Fransen van de Putte EE, Zareba P, Koskinen I, Kassouf W, Traboulsi SL, Kukreja JE, Boström PJ, Shayegan B, Pinthus JH.
Increased expression of fibroblast growth factor 13 in prostate cancer is associated with shortened time to biochemical recurrence after radical prostatectomy (2016)
- International Journal of Cancer
Yu L, Toriseva M, Tuomala M, Seikkula H, Elo T, Tuomela J, Kallajoki M, Mirtti T, Taimen P, Bostrom PJ, Alanen K, Nurmi M, Nees M, Harkonen P
Initiation of robot-assisted radical prostatectomies in Finland: Impact on centralization and quality of care (2016)
- Scandinavian Journal of Urology
Riikonen J, Kaipia A, Petas A, Horte A, Koskimaki J, Kahkonen E, Bostrom PJ, Paananen I, Kuisma J, Santti H, Matikainen M, Rannikko A
Intravesical Bacillus Calmette-Guerin Versus Combination of Epirubicin and Interferon-alpha 2a in Reducing Recurrence of Non-Muscle-invasive Bladder Carcinoma: FinnBladder-6 Study (2016)
- European Urology
Timo Marttila, Riikka Järvinen, Tapani Liukkonen, Erkki Rintala, Peter Boström, Marjo Seppänen, Teuvo Tammela, Pekka Hellström, Sirpa Aaltomaa, Markku Leskinen, Mika Raitanen, Eero Kaasinen